Compounds > 4-carboxy-3-hydroxyphenylglycine
Page last updated: 2024-10-21

4-carboxy-3-hydroxyphenylglycine and Cerebral Infarction

4-carboxy-3-hydroxyphenylglycine has been researched along with Cerebral Infarction in 1 studies

4-carboxy-3-hydroxyphenylglycine: weak agonist at metabotropic glutamate receptors; occludes the action of 1-aminocyclopentyl-1,3-dicarboxylate in hippocampus

Cerebral Infarction: The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rauca, C1
Henrich-Noack, P1
Schäfer, K1
Höllt, V1
Reymann, KG1

Other Studies

1 other study available for 4-carboxy-3-hydroxyphenylglycine and Cerebral Infarction

ArticleYear
(S)-4C3HPG reduces infarct size after focal cerebral ischemia.
    Neuropharmacology, 1998, Volume: 37, Issue:12

    Topics: Animals; Cerebral Infarction; Cerebral Ventricles; Glycine; Injections, Intraventricular; Ischemic A

1998